Imthera Medical, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Imthera Medical, Inc.
Deals Shaping the Medical Industry, January 2018
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in December 2017.
M&A Analysis: M&A Rises In 2017 As Market Set To Bounce Back In 2018
2017 proved to be a busy year for medtech M&A activity, with the number of deals rising from 174 in 2016, to 206 in 2017. The year also brought a number of notable acquisitions, including Becton Dickinson's blockbuster $24bn purchase of CR Bard and Dutch health-care giant Philips undertaking an ambitious acquisition spree. Medtech Insight takes a look at the highlights of 2017 and what's in store for 2018.
Electroceuticals: Drug-Like Effects, Without The Drugs
Electroceuticals could replace the use of pharmaceuticals in many chronic diseases, offering effective treatments without, perhaps, side effects. Medtechs pioneering these next-gen neuromodulation devices are sparking investor interest.
ImThera Gets Go-Ahead For Sleep Apnea Nerve Stimulator Pivotal Study
The aura6000 sleep apnea system has received investigational device exemption approval for a pivotal trial but still lags behind key rival Inspire Medical Systems Inc.’s Inspire upper airway stimulator.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.